GlassScriptPhysician profile
Lorraine Rabadi
NPI 1548825953
$6,916.42
in general payments reported to CMS, 2019-2025
27 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $73.99 · 2022: $424 · 2023: $3,269 · 2024: $1,285 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,904 · Travel and Lodging: $1,487 · Education: $27.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,904.27 |
| Travel and Lodging | $1,486.79 |
| Education | $27.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,099.60 | 2022-2025 | Interstim |
| Teleflex LLC | $1,446.88 | 2022-2025 | Urolift, Barrigel, Solesta |
| Axonics, INC. | $802.64 | 2023-2024 | Axonics |
| Boston Scientific Corporation | $529.09 | 2022-2025 | Axonics, Solyx Sis System, Spaceoar System |
| Sumitomo Pharma America, INC. | $384.48 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $283.71 | 2024 | Soltive, Uretero-Reno Fiberscope, Cysto-Nephro Videoscope |
| Novo Nordisk INC | $266.00 | 2023-2025 | Wegovy |
| Phathom Pharmaceuticals, INC. | $250.00 | 2024-2025 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $135.00 | 2025 | Dupixent |
| Smith+Nephew, INC. | $115.22 | 2022 | |
| Endo Pharmaceuticals INC. | $102.27 | 2023 | Xiaflex |
| Stimlabs LLC | $85.26 | 2025 | Geistlich Derma-Gide, Corplex P |
| Hollister Incorporated | $63.46 | 2021-2022 | |
| Pfizer INC. | $49.73 | 2024-2025 | |
| Procept Biorobotics Corporation | $30.95 | 2023 | Aquabeam Robotic System |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $28.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.36 | 2024 | |
| 180 Medical, INC. | $25.60 | 2025 | |
| Janssen Biotech, INC. | $25.46 | 2022 | |
| Urogen Pharma, INC. | $24.48 | 2023 | Jelmyto |
| Laborie Medical Technologies Corp. | $23.11 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urovant Sciences INC | $23.10 | 2021 | |
| Abc Home Medical Supply, INC. | $22.16 | 2024 | |
| Ferring Pharmaceuticals INC. | $19.30 | 2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $18.59 | 2025 | |
| Myriad Genetic Laboratories, INC. | $17.14 | 2022 | |
| Astellas Pharma US INC | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Rabadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.